SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

BLISS GVS PHARMA

BSE: 506197 29 Sep 2025
Healthcare
₹ 152.2
Bliss GVS Pharma Limited specializes in Pharmaceuticals within the Healthcare sector.

BLISS GVS PHARMA - Share Price & Details

Market Cap
₹1,529
High /Low
191.0 / 105.0
Stock P/E
14.3
Book Value
₹99.7
Dividend Yield
0.35
ROCE
11.7
ROE
₹8.36
Face Value
1.0
PEG Ratio
0.33
EVEBITDA
₹6.97
Debt
88.1
CMP / FCF
93.0
Debt to equity
₹0.08
NP Ann
90.3
High price all time
230.0
Piotroski score
₹4.0
Graham Number
151.0
No. Eq. Shares
10.6
Net CF
₹0.23
Net profit
112
Price to book value
1.45
Interest Coverage
₹14.2
Low price all time
0.95
Industry PE
33.0
Reserves
₹1,040
Free Cash Flow
₹33.0

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
BLISS GVS PHARMA LTD.1739.57210.531633.641.981,52914.3
Shukra Pharmaceuticals LimitedNANANANA1510149.0
Bajaj Healthcare Limited1497.14118.341488.363.75149231.7

Peer Comparison Chart


About BLISS GVS PHARMA

Bliss GVS Pharma Limited, with Security Code 506197, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Will Fed Rate Hikes Affect Bliss GVS Pharma Limited Stocks Outlook - Value Stock Picks & Small Investment Portfolio

(27 Sep 2025)
Will Fed Rate Hikes Affect Bliss GVS Pharma Limited Stocks Outlook ✌️【Stock Trends】✌️ Our members enjoy access to high-conviction investment...
Read more →

Will Fed Rate Hikes Affect Bliss GVS Pharma Limited Stocks Outlook - Mid Cap Growth Trends & Double Or Triple Wealth

(27 Sep 2025)
Will Fed Rate Hikes Affect Bliss GVS Pharma Limited Stocks Outlook ✌️【Stock Watchlist】✌️ Real-time stock data and market insights to help...
Read more →

What Is the Future of Bliss GVS Pharma Limited Stock Expert Projections Explained - Price Volatility Patterns & Rapid Capital Growth

(27 Sep 2025)
【Stock Observations】✌️ Boost your returns with stock picks based on real-time indicators, institutional analysis, and ongoing expert...
Read more →

BLISSGVS Share Price Today - Bliss GVS Pharma Stock Analysis

(18 Sep 2025)
Bliss GVS Pharma share price today- Get BLISSGVS historical data, financial data, buy/sell, targets, technical & fundamental analysis, BLISSGVS chart,...
Read more →

Global Suppositories Market to Surpass USD 2.05 Billion by 2030 | MarketsandMarkets™

(27 Aug 2025)
Rising demand for localized treatment options and innovation in pharmaceutical technologies are reshaping the suppositories market landscape...
Read more →

Bliss GVS Pharma Reports Mixed Financial Results with Significant Growth and Rising Costs in June 2025

(08 Aug 2025)
Bliss GVS Pharma has announced its financial results for the quarter ending June 2025, showing significant year-on-year growth in Profit After Tax and...
Read more →